Clinical Trial Update: A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 study evaluating ASP1941 in Asian subjects with Type 2 diabetes mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ASP1941

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type II Diabetes Mellitus | Phase 3 | Status: TERMINATED